FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to medicine and pharmacology, and represents an immunostimulating drug of mucosal application in the form of lozenge containing interferon and excipients comprising carbohydrates, differing by the fact that the excipients are water-soluble synthetic polymer polyvinylpyrrolidone (1000000-1500000) with the trading name kollidon 90 F, sodium benzoate, a composition of lactose carbohydrates and saccharose with the ingredients taken in certain proportions, wt % dry basis.
EFFECT: invention provides a prolonged effect on immune cell of oral mucosa and tonsils due to slow oral disintegration.
3 cl, 7 tbl, 3 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN INTERLEUKIN-2 BASE ANTITUMOR AGENT SHOWING LOCAL-RESORPTIVE EFFECT | 1995 |
|
RU2117472C1 |
| ANALGETIC AND ANTI-ITCHING AGENT | 1997 |
|
RU2147440C1 |
| SUBLINGUAL TABLET MEDICINAL PREPARATION COMPRISING ALPHA- INTERFERON AND METHOD FOR ITS PREPARING | 2003 |
|
RU2234939C1 |
| SOLID PROLONGED-RELEASE DOSAGE FORM OF NON-STEROIDAL ANTI-INFLAMMATORY DRUG KETOPROFEN, METHOD FOR PREPARING IT | 2011 |
|
RU2448690C1 |
| PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING INFECTIOUS-INFLAMMATORY DISEASES OF VARIOUS ORIGINS BY OROMUCOSAL ADMINISTRATION | 2013 |
|
RU2538433C1 |
| COMPOSITION BASED ON INTERFERON I OR III TYPE AND GAMMA-D-GLUTAMINYL-L-TRYPTOPHAN FOR PREVENTION AND TREATMENT OF INFECTIOUS DISEASES AND IMMUNODEFICIENCY CONDITIONS (OPTIONS) | 2014 |
|
RU2672861C2 |
| MEDICINE FOR BIRD INFLUENZA TREATMENT | 2007 |
|
RU2332236C1 |
| COMBINED ANTITUBERCULOUS PHARMACEUTICAL COMPOSITION | 2010 |
|
RU2436580C1 |
| PHARMACEUTICAL ANTI-TUBERCULOSIS COMBINED COMPOSITION | 2009 |
|
RU2424808C2 |
| COMPOSITION FOR TREATING MULTIPLE SCLEROSIS (VERSIONS) | 2012 |
|
RU2493845C1 |
